AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

"Comparative Study of High-frequency Pulsed Vacuum Technology Versus Phacoemulsification for Cataract Surgery

RecruitingNAAges 18 Years - anyAllClinique Victor Pauchet
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cataracts are cloudings of the lens, primarily due to aging. Surgery is the primary treatment for cataracts. The most commonly used surgical technique is phacoemulsification, which involves fragmenting the lens using a high-frequency ultrasound probe and removing the fragments. Phacoemulsification is more common due to its advantages. Recently, a new approach has emerged, using high-frequency pulsed vacuum technology for cataract ablation. This less invasive approach is expected to allow for faster patient recovery and reduce surgical risks. High-frequency pulsed vacuum utilizes the pulse-pulse principle by interrupting the vacuum every tenth of a second. This interruption creates an impact moment between the cataract material and the cannula tip, dissecting the cataract without damaging the surrounding delicate tissue. High-frequency pulsed vacuum maintains anterior chamber stability w

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Adult patient * Patient with bilateral cataracts * Grade 1 to 3 cataracts * Indication for bilateral cataract surgery * Patient informed of the study and having given their written and signed informed consent * Patient affiliated with a social security scheme or beneficiary of such a scheme Exclusion Criteria: * Refusal of consent * Cataract grade \> 3 * Unilateral and/or combined cataract surgery * Uveitic cataract * Glaucoma * Patient with ocular comorbidity * Patient with cognitive impairment preventing them from responding to satisfaction questionnaires * Patient unable to read, write, or understand French * Pregnant or breastfeeding patient as defined in Article L1121-5 of the French Public Health Code * Vulnerable patient as defined in Article L1121-6 of the French Public Health Code * Adult patient under guardianship, curatorship, or legal protection * Patient unable to give personal consent
๐Ÿ’Š

What it tests

  • Eye 1 by the Technique by high-frequency pulsed vacuum technology
  • Eye 2 : Surgery byTechnique by high-frequency pulsed vacuum technology
๐Ÿ“

Where

1 site
Clinique Victor Pauchet
Amiens, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy